Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

To Compare the Efficacy and Safety of TW vs Valsartan in the DN.

Trial Profile

To Compare the Efficacy and Safety of TW vs Valsartan in the DN.

Phase of Trial: Phase II

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Tripterygium wilfordii Hook F (Primary) ; Valsartan
  • Indications Diabetic nephropathies
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 26 May 2010 Actual patient number (67) added as reported by ClinicalTrials.gov.
    • 26 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top